Can psilocybin alleviate phantom limb pain? 5 questions with neuroscientist Fadel Zeidan
Zeidan discusses how magic mushrooms might help reduce amputees’ pain.
External link. We are not responsible for the content.
Read more ↗More From The Microdose (Berkeley)
What might the FDA Commissioner’s resignation mean for psychedelics? Ketamine infusions rapidly reduce suicidal and depressive symptoms during major depressive episodes
Plus: Could psychedelic-assisted therapy help improve adolescents’ mental health? National poll reflects “cautious su...
Do psychedelics lead to major life changes? 5 Questions with health behaviorist Nic Carlisle
Carlisle discusses how common it is to upturn your life after a trip.
Psilocybin changes people’s brains after their first trip; Anthropologists share first evidence of traditional psilocybin use outside of the Americas
Plus: A pair of ketamine mechanism studies; Trump’s executive order revives analysis into Republicans’ pro-psychedeli...
Latest News
What Happens When You Feel Like Jesus After Taking Psychedelics?
Experts explain why some psychedelic trips end in claims of divinity — and when it becomes a problem. [...] Read More...
Truffles, therapy, disciplinary law – An OPEN perspective on the grey area in which (licensed) therapists operate in the Netherlands with regard to psychedelics
Read this article in Dutch here. On May 8, 2026, the Amsterdam Healthcare Disciplinary Board ruled on a significant c...
LSD microdosing for major depressive disorder: Mood and pharmacokinetic outcomes from a Phase 2a trial
Repeated microdosing of LSD (8 to 20 μg) may help improve daily mood, specifically increasing feelings of connection,...
It’s all about the relationship: The caregiver experience of supporting a person with advanced cancer going through an LSD microdosing trial
Caregivers of people with advanced cancer often find that psychedelic-assisted therapy can strengthen their relations...
Epidemiology of Hallucinogen Microdosing Among Young Adults in the United States: A National Study
About 1 in 15 young adults in the United States reported microdosing hallucinogens in the past year.
Comparing single- and repeat-dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trial
Low doses of psilocybin may reduce the frequency of migraine attacks, but a two-dose "pulsed" schedule did not show a...